Iscom of viral envelope proteins protects against Aujeszky's disease.
An immunostimulating complex (iscom) containing the envelope proteins of pseudorabies virus (PRV) was prepared and its efficacy was evaluated in two experiments on sheep. In the first experiment, sheep were intramuscularly (i.m.) or intradermally (i.d.) vaccinated with PRV iscom doses varying between 1 and 81 micrograms. The vaccination was repeated on Day 21 and the animals were exposed to challenge infection by subcutaneous inoculation of 1000 TCID50 of the virulent Phylaxia strain on Day 35 after first vaccination. In the second experiment, sheep were i.m. vaccinated with single doses of iscom varying between 1 and 27 micrograms and challenge-infected on Day 14. It was found that: (1) the i.d. administration of PRV iscom has no advantage over i.m. administration (2); a single dose of greater than or equal to 3 micrograms of PRV iscom provided protection against the disease. In immunoblots, viral proteins of molecular masses 120, 109, 55, 53 and 32 kDa were detected with the sera obtained from iscom-vaccinated and subsequently challenge-infected sheep, but not with sera from sheep which were iscom-vaccinated only. The above findings indicated that: (1) by using iscom technology, potent subunit vaccines can be prepared to prevent Aujeszky's disease; (2) the selective incorporation of viral envelope proteins into iscoms gives the opportunity to discriminate between iscom-vaccinated and naturally infected animals.
Morein
B
B
Department of Virology, National Veterinary Institute, Uppsala, Sweden.
Belák
S
S
Soós
T
T
Rusvai
M
M
McGwire
B S
BS
Bognár
K
K
D000276:Adjuvants, Immunologic; D000818:Animals; D015153:Blotting, Western; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D011558:Herpesvirus 1, Suid / Q000276:immunology*; D008854:Microscopy, Electron; D009500:Neutralization Tests; D011557:Pseudorabies / Q000517:prevention & control*; D012756:Sheep; D014611:Vaccination / Q000662:veterinary*; D014759:Viral Envelope Proteins / Q000032:analysis / Q000276:immunology*; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D014759:Viral Envelope Proteins; D014765:Viral Vaccines